ID   RELN_HUMAN              Reviewed;        3460 AA.
AC   P78509; A4D0P9; A4D0Q0; Q86UJ0; Q86UJ8; Q8NDV0; Q9UDQ2;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   07-APR-2021, entry version 195.
DE   RecName: Full=Reelin;
DE            EC=3.4.21.-;
DE   Flags: Precursor;
GN   Name=RELN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9049633; DOI=10.1101/gr.7.2.157;
RA   DeSilva U., D'Arcangelo G., Braden V.V., Chen J., Miao G.G., Curran T.,
RA   Green E.D.;
RT   "The human reelin gene: isolation, sequencing, and mapping on chromosome
RT   7.";
RL   Genome Res. 7:157-164(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   ALTERNATIVE SPLICING.
RX   PubMed=10328932; DOI=10.1006/exnr.1999.7019;
RA   Lambert de Rouvroit C., Bernier B., Royaux I., de Bergeyck V.,
RA   Goffinet A.M.;
RT   "Evolutionarily conserved, alternative splicing of reelin during brain
RT   development.";
RL   Exp. Neurol. 156:229-238(1999).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=9861036; DOI=10.1073/pnas.95.26.15718;
RA   Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H.,
RA   Pisu M.G., Uzunov D.P., Smalheiser N.R., Davis J.M., Pandey G.N.,
RA   Pappas G.D., Tueting P., Sharma R.P., Costa E.;
RT   "A decrease of reelin expression as a putative vulnerability factor in
RT   schizophrenia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:15718-15723(1998).
RN   [6]
RP   INVOLVEMENT IN LIS2.
RX   PubMed=10973257; DOI=10.1038/79246;
RA   Hong S.E., Shugart Y.Y., Huang D.T., Shahwan S.A., Grant P.E.,
RA   Hourihane J.O.B., Martin N.D.T., Walsh C.A.;
RT   "Autosomal recessive lissencephaly with cerebellar hypoplasia is associated
RT   with human RELN mutations.";
RL   Nat. Genet. 26:93-96(2000).
RN   [7]
RP   ERRATUM OF PUBMED:10973257.
RA   Hong S.E., Shugart Y.Y., Huang D.T., Shahwan S.A., Grant P.E.,
RA   Hourihane J.O.B., Martin N.D.T., Walsh C.A.;
RL   Nat. Genet. 27:225-225(2001).
RN   [8]
RP   POLYMORPHISM.
RX   PubMed=11317216; DOI=10.1038/sj.mp.4000850;
RA   Persico A.M., D'Agruma L., Maiorano N., Totaro A., Militerni R.,
RA   Bravaccio C., Wassink T.H., Schneider C., Melmed R., Trillo S.,
RA   Montecchi F., Palermo M., Pascucci T., Puglisi-Allegra S., Reichelt K.-L.,
RA   Conciatori M., Marino R., Quattrocchi C.C., Baldi A., Zelante L.,
RA   Gasparini P., Keller F.;
RT   "Reelin gene alleles and haplotypes as a factor predisposing to autistic
RT   disorder.";
RL   Mol. Psychiatry 6:150-159(2001).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-305; ASN-1920 AND ASN-3015.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   INVOLVEMENT IN ETL7, AND VARIANTS ETL7 LEU-672; CYS-723; GLY-763; ASN-798;
RP   LEU-844; CYS-2783 AND LYS-3176.
RX   PubMed=26046367; DOI=10.1016/j.ajhg.2015.04.020;
RA   Dazzo E., Fanciulli M., Serioli E., Minervini G., Pulitano P., Binelli S.,
RA   Di Bonaventura C., Luisi C., Pasini E., Striano S., Striano P., Coppola G.,
RA   Chiavegato A., Radovic S., Spadotto A., Uzzau S., La Neve A.,
RA   Giallonardo A.T., Mecarelli O., Tosatto S.C., Ottman R., Michelucci R.,
RA   Nobile C.;
RT   "Heterozygous reelin mutations cause autosomal-dominant lateral temporal
RT   epilepsy.";
RL   Am. J. Hum. Genet. 96:992-1000(2015).
CC   -!- FUNCTION: Extracellular matrix serine protease that plays a role in
CC       layering of neurons in the cerebral cortex and cerebellum. Regulates
CC       microtubule function in neurons and neuronal migration. Affects
CC       migration of sympathetic preganglionic neurons in the spinal cord,
CC       where it seems to act as a barrier to neuronal migration. Enzymatic
CC       activity is important for the modulation of cell adhesion. Binding to
CC       the extracellular domains of lipoprotein receptors VLDLR and
CC       LRP8/APOER2 induces tyrosine phosphorylation of DAB1 and modulation of
CC       TAU phosphorylation (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Oligomer of disulfide-linked homodimers. Binds to the
CC       ectodomains of VLDLR and LRP8/APOER2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P78509-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78509-2; Sequence=VSP_005575;
CC       Name=3;
CC         IsoId=P78509-3; Sequence=VSP_005576;
CC   -!- TISSUE SPECIFICITY: Abundantly produced during brain ontogenesis by the
CC       Cajal-Retzius cells and other pioneer neurons located in the
CC       telencephalic marginal zone and by granule cells of the external
CC       granular layer of the cerebellum. In adult brain, preferentially
CC       expressed in GABAergic interneurons of prefrontal cortices, temporal
CC       cortex, hippocampus and glutamatergic granule cells of cerebellum.
CC       Expression is reduced to about 50% in patients with schizophrenia. Also
CC       expressed in fetal and adult liver. {ECO:0000269|PubMed:9861036}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal and postnatal brain and liver.
CC       Expression in postnatal human brain is high in the cerebellum.
CC   -!- DOMAIN: The basic C-terminal region is essential for secretion.
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: A polymorphic GGC triplet repeat located in the 5'-UTR
CC       region of RELN gene, which harbors in the normal population 8 to 10
CC       repeats, is significantly increased in autistic patients to carry 4 to
CC       23 additional repeats. {ECO:0000269|PubMed:11317216}.
CC   -!- DISEASE: Lissencephaly 2 (LIS2) [MIM:257320]: A classic type
CC       lissencephaly associated with ataxia, mental retardation, seizures and
CC       abnormalities of the cerebellum, hippocampus and brainstem.
CC       {ECO:0000269|PubMed:10973257}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]: A
CC       focal form of epilepsy characterized by recurrent seizures that arise
CC       from foci within the temporal lobe. Seizures are usually accompanied by
CC       sensory symptoms, most often auditory in nature.
CC       {ECO:0000269|PubMed:26046367}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the reelin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Reelin entry;
CC       URL="https://en.wikipedia.org/wiki/Reelin";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U79716; AAC51105.1; -; mRNA.
DR   EMBL; AC002067; AAM49151.1; -; Genomic_DNA.
DR   EMBL; AC006981; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073208; AAP22355.1; -; Genomic_DNA.
DR   EMBL; AC005101; AAP22330.1; -; Genomic_DNA.
DR   EMBL; AC000121; AAB46357.2; -; Genomic_DNA.
DR   EMBL; AC006316; AAD29127.1; -; Genomic_DNA.
DR   EMBL; AC005064; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236947; EAL24410.1; -; Genomic_DNA.
DR   EMBL; CH236947; EAL24411.1; -; Genomic_DNA.
DR   CCDS; CCDS34722.1; -. [P78509-2]
DR   CCDS; CCDS47680.1; -. [P78509-1]
DR   RefSeq; NP_005036.2; NM_005045.3. [P78509-1]
DR   RefSeq; NP_774959.1; NM_173054.2. [P78509-2]
DR   SMR; P78509; -.
DR   BioGRID; 111630; 12.
DR   ComplexPortal; CPX-4424; Reelin complex.
DR   IntAct; P78509; 1.
DR   STRING; 9606.ENSP00000392423; -.
DR   GlyConnect; 1972; 11 N-Linked glycans (6 sites).
DR   GlyGen; P78509; 22 sites, 2 O-linked glycans (1 site).
DR   iPTMnet; P78509; -.
DR   PhosphoSitePlus; P78509; -.
DR   BioMuta; RELN; -.
DR   DMDM; 296452988; -.
DR   MassIVE; P78509; -.
DR   MaxQB; P78509; -.
DR   PaxDb; P78509; -.
DR   PeptideAtlas; P78509; -.
DR   PRIDE; P78509; -.
DR   ProteomicsDB; 57628; -. [P78509-1]
DR   ProteomicsDB; 57629; -. [P78509-2]
DR   ProteomicsDB; 57630; -. [P78509-3]
DR   Antibodypedia; 3876; 222 antibodies.
DR   Ensembl; ENST00000343529; ENSP00000345694; ENSG00000189056. [P78509-2]
DR   Ensembl; ENST00000428762; ENSP00000392423; ENSG00000189056. [P78509-1]
DR   GeneID; 5649; -.
DR   KEGG; hsa:5649; -.
DR   UCSC; uc010liz.3; human. [P78509-1]
DR   CTD; 5649; -.
DR   DisGeNET; 5649; -.
DR   GeneCards; RELN; -.
DR   GeneReviews; RELN; -.
DR   HGNC; HGNC:9957; RELN.
DR   HPA; ENSG00000189056; Group enriched (brain, liver).
DR   MalaCards; RELN; -.
DR   MIM; 257320; phenotype.
DR   MIM; 600514; gene.
DR   MIM; 616436; phenotype.
DR   neXtProt; NX_P78509; -.
DR   OpenTargets; ENSG00000189056; -.
DR   Orphanet; 101046; Autosomal dominant epilepsy with auditory features.
DR   Orphanet; 89844; Lissencephaly syndrome, Norman-Roberts type.
DR   PharmGKB; PA34323; -.
DR   VEuPathDB; HostDB:ENSG00000189056.13; -.
DR   eggNOG; ENOG502QSIP; Eukaryota.
DR   GeneTree; ENSGT00580000081623; -.
DR   HOGENOM; CLU_000468_0_0_1; -.
DR   InParanoid; P78509; -.
DR   OMA; SDNYSGW; -.
DR   OrthoDB; 9177at2759; -.
DR   PhylomeDB; P78509; -.
DR   TreeFam; TF106479; -.
DR   PathwayCommons; P78509; -.
DR   Reactome; R-HSA-8866376; Reelin signalling pathway.
DR   SIGNOR; P78509; -.
DR   BioGRID-ORCS; 5649; 5 hits in 998 CRISPR screens.
DR   ChiTaRS; RELN; human.
DR   GeneWiki; Reelin; -.
DR   GenomeRNAi; 5649; -.
DR   Pharos; P78509; Tbio.
DR   PRO; PR:P78509; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P78509; protein.
DR   Bgee; ENSG00000189056; Expressed in cerebellar hemisphere and 226 other tissues.
DR   ExpressionAtlas; P78509; baseline and differential.
DR   Genevisible; P78509; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0070325; F:lipoprotein particle receptor binding; ISS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008236; F:serine-type peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0070326; F:very-low-density lipoprotein particle receptor binding; ISS:BHF-UCL.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0000904; P:cell morphogenesis involved in differentiation; ISS:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; ISS:UniProtKB.
DR   GO; GO:0021800; P:cerebral cortex tangential migration; ISS:UniProtKB.
DR   GO; GO:0010001; P:glial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; ISS:BHF-UCL.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISS:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; ISS:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:2000969; P:positive regulation of AMPA receptor activity; ISS:BHF-UCL.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; ISS:BHF-UCL.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:BHF-UCL.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; ISS:BHF-UCL.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; ISS:BHF-UCL.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:BHF-UCL.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; ISS:BHF-UCL.
DR   GO; GO:0051057; P:positive regulation of small GTPase mediated signal transduction; ISS:UniProtKB.
DR   GO; GO:0090129; P:positive regulation of synapse maturation; ISS:BHF-UCL.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL.
DR   GO; GO:0038026; P:reelin-mediated signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0050795; P:regulation of behavior; ISS:BHF-UCL.
DR   GO; GO:2000310; P:regulation of NMDA receptor activity; ISS:BHF-UCL.
DR   GO; GO:0048265; P:response to pain; ISS:UniProtKB.
DR   GO; GO:0021511; P:spinal cord patterning; ISS:UniProtKB.
DR   CDD; cd08544; Reeler; 1.
DR   Gene3D; 2.60.120.260; -; 18.
DR   Gene3D; 2.60.40.4060; -; 1.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR041161; EGF_Tenascin.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR002861; Reeler_dom.
DR   InterPro; IPR042307; Reeler_sf.
DR   InterPro; IPR034968; Reelin.
DR   InterPro; IPR036278; Sialidase_sf.
DR   PANTHER; PTHR11841; PTHR11841; 12.
DR   Pfam; PF18720; EGF_Tenascin; 1.
DR   Pfam; PF02014; Reeler; 1.
DR   SMART; SM00181; EGF; 8.
DR   SUPFAM; SSF50939; SSF50939; 4.
DR   PROSITE; PS00022; EGF_1; 7.
DR   PROSITE; PS01186; EGF_2; 6.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS51019; REELIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Developmental protein;
KW   Disease variant; Disulfide bond; EGF-like domain; Epilepsy;
KW   Extracellular matrix; Glycoprotein; Hydrolase; Lissencephaly;
KW   Metal-binding; Protease; Reference proteome; Repeat; Secreted;
KW   Serine protease; Signal; Zinc.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..3460
FT                   /note="Reelin"
FT                   /id="PRO_0000030304"
FT   DOMAIN          26..190
FT                   /note="Reelin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00363"
FT   REPEAT          592..603
FT                   /note="BNR 1"
FT   DOMAIN          670..701
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          798..809
FT                   /note="BNR 2"
FT   REPEAT          951..962
FT                   /note="BNR 3"
FT   DOMAIN          1029..1060
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          1156..1167
FT                   /note="BNR 4"
FT   REPEAT          1322..1333
FT                   /note="BNR 5"
FT   DOMAIN          1408..1441
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          1534..1545
FT                   /note="BNR 6"
FT   REPEAT          1685..1696
FT                   /note="BNR 7"
FT   DOMAIN          1764..1795
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          1883..1894
FT                   /note="BNR 8"
FT   REPEAT          2042..2053
FT                   /note="BNR 9"
FT   DOMAIN          2128..2160
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          2249..2260
FT                   /note="BNR 10"
FT   REPEAT          2398..2409
FT                   /note="BNR 11"
FT   DOMAIN          2477..2508
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          2597..2608
FT                   /note="BNR 12"
FT   REPEAT          2777..2788
FT                   /note="BNR 13"
FT   DOMAIN          2852..2883
FT                   /note="EGF-like 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          2978..2989
FT                   /note="BNR 14"
FT   REPEAT          3142..3154
FT                   /note="BNR 15"
FT   DOMAIN          3227..3259
FT                   /note="EGF-like 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          3362..3373
FT                   /note="BNR 16"
FT   COMPBIAS        3431..3460
FT                   /note="Arg-rich (basic)"
FT   METAL           2060
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           2073
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           2178
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           2263
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           2396
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           2398
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           2459
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        289
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        305
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        628
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1266
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1599
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1749
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1920
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        2144
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2268
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2316
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2568
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2961
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3015
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        3072
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3411
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3438
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        40..126
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        154..178
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        539..580
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        608..613
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        674..684
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        691..700
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        894..936
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        967..974
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        1033..1043
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        1050..1059
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        1270..1309
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        1338..1347
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        1632..1672
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        1701..1708
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2100
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2132..2142
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2136..2148
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2150..2159
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2194..2234
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2347..2386
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2392..2558
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2543..2583
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2793..2800
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2856..2866
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2860..2871
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2873..2882
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        2918..2965
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        3159..3169
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        3231..3241
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        3235..3247
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        3249..3258
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        3295..3345
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   VAR_SEQ         3428..3460
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005576"
FT   VAR_SEQ         3428..3429
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005575"
FT   VARIANT         672
FT                   /note="P -> L (in ETL7; dbSNP:rs201044262)"
FT                   /evidence="ECO:0000269|PubMed:26046367"
FT                   /id="VAR_073862"
FT   VARIANT         723
FT                   /note="Y -> C (in ETL7; dbSNP:rs768119894)"
FT                   /evidence="ECO:0000269|PubMed:26046367"
FT                   /id="VAR_073863"
FT   VARIANT         763
FT                   /note="D -> G (in ETL7; dbSNP:rs794727998)"
FT                   /evidence="ECO:0000269|PubMed:26046367"
FT                   /id="VAR_073864"
FT   VARIANT         798
FT                   /note="H -> N (in ETL7; dbSNP:rs794727996)"
FT                   /evidence="ECO:0000269|PubMed:26046367"
FT                   /id="VAR_073865"
FT   VARIANT         844
FT                   /note="P -> L (in ETL7; dbSNP:rs797045000)"
FT                   /evidence="ECO:0000269|PubMed:26046367"
FT                   /id="VAR_073866"
FT   VARIANT         978
FT                   /note="T -> A (in dbSNP:rs3025962)"
FT                   /id="VAR_047977"
FT   VARIANT         997
FT                   /note="L -> V (in dbSNP:rs362691)"
FT                   /id="VAR_047978"
FT   VARIANT         1703
FT                   /note="P -> R (in dbSNP:rs2229860)"
FT                   /id="VAR_057712"
FT   VARIANT         2783
FT                   /note="G -> C (in ETL7; dbSNP:rs794727997)"
FT                   /evidence="ECO:0000269|PubMed:26046367"
FT                   /id="VAR_073867"
FT   VARIANT         3176
FT                   /note="E -> K (in ETL7; dbSNP:rs794727999)"
FT                   /evidence="ECO:0000269|PubMed:26046367"
FT                   /id="VAR_073868"
FT   CONFLICT        752
FT                   /note="D -> E (in Ref. 1; AAC51105)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   3460 AA;  388388 MW;  9A398EC17FA4EE1B CRC64;
     MERSGWARQT FLLALLLGAT LRARAAAGYY PRFSPFFFLC THHGELEGDG EQGEVLISLH
     IAGNPTYYVP GQEYHVTIST STFFDGLLVT GLYTSTSVQA SQSIGGSSAF GFGIMSDHQF
     GNQFMCSVVA SHVSHLPTTN LSFIWIAPPA GTGCVNFMAT ATHRGQVIFK DALAQQLCEQ
     GAPTDVTVHP HLAEIHSDSI ILRDDFDSYH QLQLNPNIWV ECNNCETGEQ CGAIMHGNAV
     TFCEPYGPRE LITTGLNTTT ASVLQFSIGS GSCRFSYSDP SIIVLYAKNN SADWIQLEKI
     RAPSNVSTII HILYLPEDAK GENVQFQWKQ ENLRVGEVYE ACWALDNILI INSAHRQVVL
     EDSLDPVDTG NWLFFPGATV KHSCQSDGNS IYFHGNEGSE FNFATTRDVD LSTEDIQEQW
     SEEFESQPTG WDVLGAVIGT ECGTIESGLS MVFLKDGERK LCTPSMDTTG YGNLRFYFVM
     GGICDPGNSH ENDIILYAKI EGRKEHITLD TLSYSSYKVP SLVSVVINPE LQTPATKFCL
     RQKNHQGHNR NVWAVDFFHV LPVLPSTMSH MIQFSINLGC GTHQPGNSVS LEFSTNHGRS
     WSLLHTECLP EICAGPHLPH STVYSSENYS GWNRITIPLP NAALTRNTRI RWRQTGPILG
     NMWAIDNVYI GPSCLKFCSG RGQCTRHGCK CDPGFSGPAC EMASQTFPMF ISESFGSSRL
     SSYHNFYSIR GAEVSFGCGV LASGKALVFN KDGRRQLITS FLDSSQSRFL QFTLRLGSKS
     VLSTCRAPDQ PGEGVLLHYS YDNGITWKLL EHYSYLSYHE PRIISVELPG DAKQFGIQFR
     WWQPYHSSQR EDVWAIDEII MTSVLFNSIS LDFTNLVEVT QSLGFYLGNV QPYCGHDWTL
     CFTGDSKLAS SMRYVETQSM QIGASYMIQF SLVMGCGQKY TPHMDNQVKL EYSTNHGLTW
     HLVQEECLPS MPSCQEFTSA SIYHASEFTQ WRRVIVLLPQ KTWSSATRFR WSQSYYTAQD
     EWALDSIYIG QQCPNMCSGH GSCDHGICRC DQGYQGTECH PEAALPSTIM SDFENQNGWE
     SDWQEVIGGE IVKPEQGCGV ISSGSSLYFS KAGKRQLVSW DLDTSWVDFV QFYIQIGGES
     ASCNKPDSRE EGVLLQYSNN GGIQWHLLAE MYFSDFSKPR FVYLELPAAA KTPCTRFRWW
     QPVFSGEDYD QWAVDDIIIL SEKQKQIIPV INPTLPQNFY EKPAFDYPMN QMSVWLMLAN
     EGMVKNETFC AATPSAMIFG KSDGDRFAVT RDLTLKPGYV LQFKLNIGCA NQFSSTAPVL
     LQYSHDAGMS WFLVKEGCYP ASAGKGCEGN SRELSEPTMY HTGDFEEWTR ITIVIPRSLA
     SSKTRFRWIQ ESSSQKNVPP FGLDGVYISE PCPSYCSGHG DCISGVCFCD LGYTAAQGTC
     VSNVPNHNEM FDRFEGKLSP LWYKITGAQV GTGCGTLNDG KSLYFNGPGK REARTVPLDT
     RNIRLVQFYI QIGSKTSGIT CIKPRTRNEG LIVQYSNDNG ILWHLLRELD FMSFLEPQII
     SIDLPQDAKT PATAFRWWQP QHGKHSAQWA LDDVLIGMND SSQTGFQDKF DGSIDLQANW
     YRIQGGQVDI DCLSMDTALI FTENIGKPRY AETWDFHVSA STFLQFEMSM GCSKPFSNSH
     SVQLQYSLNN GKDWHLVTEE CVPPTIGCLH YTESSIYTSE RFQNWKRITV YLPLSTISPR
     TRFRWIQANY TVGADSWAID NVVLASGCPW MCSGRGICDA GRCVCDRGFG GPYCVPVVPL
     PSILKDDFNG NLHPDLWPEV YGAERGNLNG ETIKSGTSLI FKGEGLRMLI SRDLDCTNTM
     YVQFSLRFIA KSTPERSHSI LLQFSISGGI TWHLMDEFYF PQTTNILFIN VPLPYTAQTN
     ATRFRLWQPY NNGKKEEIWI VDDFIIDGNN VNNPVMLLDT FDFGPREDNW FFYPGGNIGL
     YCPYSSKGAP EEDSAMVFVS NEVGEHSITT RDLNVNENTI IQFEINVGCS TDSSSADPVR
     LEFSRDFGAT WHLLLPLCYH SSSHVSSLCS TEHHPSSTYY AGTMQGWRRE VVHFGKLHLC
     GSVRFRWYQG FYPAGSQPVT WAIDNVYIGP QCEEMCNGQG SCINGTKCIC DPGYSGPTCK
     ISTKNPDFLK DDFEGQLESD RFLLMSGGKP SRKCGILSSG NNLFFNEDGL RMLMTRDLDL
     SHARFVQFFM RLGCGKGVPD PRSQPVLLQY SLNGGLSWSL LQEFLFSNSS NVGRYIALEI
     PLKARSGSTR LRWWQPSENG HFYSPWVIDQ ILIGGNISGN TVLEDDFTTL DSRKWLLHPG
     GTKMPVCGST GDALVFIEKA STRYVVSTDV AVNEDSFLQI DFAASCSVTD SCYAIELEYS
     VDLGLSWHPL VRDCLPTNVE CSRYHLQRIL VSDTFNKWTR ITLPLPPYTR SQATRFRWHQ
     PAPFDKQQTW AIDNVYIGDG CIDMCSGHGR CIQGNCVCDE QWGGLYCDDP ETSLPTQLKD
     NFNRAPSSQN WLTVNGGKLS TVCGAVASGM ALHFSGGCSR LLVTVDLNLT NAEFIQFYFM
     YGCLITPNNR NQGVLLEYSV NGGITWNLLM EIFYDQYSKP GFVNILLPPD AKEIATRFRW
     WQPRHDGLDQ NDWAIDNVLI SGSADQRTVM LDTFSSAPVP QHERSPADAG PVGRIAFDMF
     MEDKTSVNEH WLFHDDCTVE RFCDSPDGVM LCGSHDGREV YAVTHDLTPT EGWIMQFKIS
     VGCKVSEKIA QNQIHVQYST DFGVSWNYLV PQCLPADPKC SGSVSQPSVF FPTKGWKRIT
     YPLPESLVGN PVRFRFYQKY SDMQWAIDNF YLGPGCLDNC RGHGDCLREQ CICDPGYSGP
     NCYLTHTLKT FLKERFDSEE IKPDLWMSLE GGSTCTECGI LAEDTALYFG GSTVRQAVTQ
     DLDLRGAKFL QYWGRIGSEN NMTSCHRPIC RKEGVLLDYS TDGGITWTLL HEMDYQKYIS
     VRHDYILLPE DALTNTTRLR WWQPFVISNG IVVSGVERAQ WALDNILIGG AEINPSQLVD
     TFDDEGTSHE ENWSFYPNAV RTAGFCGNPS FHLYWPNKKK DKTHNALSSR ELIIQPGYMM
     QFKIVVGCEA TSCGDLHSVM LEYTKDARSD SWQLVQTQCL PSSSNSIGCS PFQFHEATIY
     NSVNSSSWKR ITIQLPDHVS SSATQFRWIQ KGEETEKQSW AIDHVYIGEA CPKLCSGHGY
     CTTGAICICD ESFQGDDCSV FSHDLPSYIK DNFESARVTE ANWETIQGGV IGSGCGQLAP
     YAHGDSLYFN GCQIRQAATK PLDLTRASKI MFVLQIGSMS QTDSCNSDLS GPHAVDKAVL
     LQYSVNNGIT WHVIAQHQPK DFTQAQRVSY NVPLEARMKG VLLRWWQPRH NGTGHDQWAL
     DHVEVVLVST RKQNYMMNFS RQHGLRHFYN RRRRSLRRYP
//
